metaPreg - Zolmitriptan during pregnancy

Zolmitriptan

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)	0.95 [0.52, 1.74]	27%	2 studies	56,790	506	not evaluable	ROB	-
Major congenital malformations	1.86 [0.53, 6.51]	-	1 study	11	144	not evaluable	ROB	-
Growth parameters and prematurity
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Low birth weight (< 2500g)	1.35 [0.53, 3.45]	-	1 study	19	156	not evaluable	ROB	-
Preterm (< 37 weeks)	0.96 [0.44, 2.08]	-	1 study	28	156	not evaluable	ROB	-
Small for gestational age (weight)	1.15 [0.50, 2.65]	-	1 study	24	156	not evaluable	ROB	-
Maternal consequences
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Postpartum hemorrhage	0.61 [0.13, 2.81]	-	1 study	29	17	not evaluable	ROB	-
Neonatal disorders
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Neonatal medical care	3.89 [1.08, 13.95]	-	1 study	15	17	not evaluable	ROB	7.24 [1.38; .]
Hide endpoints reported in only one study ...